GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medigen Vaccine Biologics 6547.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

48.70

+3.84%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 613.2m

FY2016FY2025

Net income

−TWD 281.7m

FY2016FY2025

Free cash flow

−TWD 100.9m

FY2016FY2025

Shareholders' equity

TWD 3.48bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 613.2mTWD 605.6mTWD 389.6mTWD 365.0mTWD 3.28bnTWD 11.5mTWD 1.1m———
Research and developmentTWD 338.6mTWD 221.5mTWD 1.19bnTWD 1.14bnTWD 1.19bnTWD 679.6mTWD 538.7mTWD 397.0mTWD 287.2mTWD 177.2m
Operating income−TWD 265.7m−TWD 145.7m−TWD 1.21bn−TWD 1.46bnTWD 1.42bn−TWD 659.3m−TWD 598.6m−TWD 466.0m−TWD 333.5m−TWD 219.6m
Net income−TWD 281.7m−TWD 80.5m−TWD 1.16bn−TWD 1.50bnTWD 1.41bn−TWD 690.7m−TWD 636.8m−TWD 476.3m−TWD 340.3m−TWD 209.6m
Diluted earnings per share-0.86-0.24-3.53-4.584.48-2.50-2.68-1.98-1.66-1.22

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 3.93bnTWD 4.36bnTWD 6.09bnTWD 7.35bnTWD 5.30bnTWD 3.49bnTWD 2.28bnTWD 2.18bnTWD 2.14bnTWD 1.82bn
Cash and short-term investments——TWD 3.76bnTWD 4.24bnTWD 2.23bnTWD 1.73bnTWD 463.9mTWD 719.6mTWD 611.0mTWD 310.0m
Total liabilitiesTWD 454.6mTWD 513.9mTWD 2.25bnTWD 2.32bnTWD 623.0mTWD 349.4mTWD 910.3mTWD 571.1mTWD 615.4mTWD 347.9m
Debt—TWD 339.0mTWD 1.97bnTWD 1.96bnTWD 185.9mTWD 187.8mTWD 797.9mTWD 523.8mTWD 570.4mTWD 322.2m
Shareholders' equityTWD 3.48bnTWD 3.85bnTWD 3.85bnTWD 5.03bnTWD 4.68bnTWD 3.14bnTWD 1.37bnTWD 1.61bnTWD 1.52bnTWD 1.47bn
Shares outstanding329m329m328m328m315m277m238m240m205m172m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−TWD 49.1mTWD 40.8m−TWD 477.8m−TWD 1.10bnTWD 579.9m−TWD 590.0m−TWD 462.6m−TWD 356.3m−TWD 217.0m−TWD 163.4m
Capital spending−TWD 51.8m−TWD 35.0m−TWD 41.0m−TWD 140.3m−TWD 135.0m−TWD 105.3m−TWD 117.4m−TWD 35.9m−TWD 89.0m−TWD 464.4m
Free cash flow−TWD 100.9mTWD 5.8m−TWD 518.7m−TWD 1.24bnTWD 444.9m−TWD 695.3m−TWD 580.0m−TWD 392.2m−TWD 306.0m−TWD 627.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 115.0mTWD 105.9mTWD 147.0mTWD 205.9mTWD 144.9mTWD 115.4mTWD 128.8mTWD 243.0m
Operating incomeTWD 21.4m−TWD 31.9m−TWD 143.0m−TWD 27.6m−TWD 62.2m−TWD 32.9m−TWD 45.0mTWD 8.7m
Net incomeTWD 22.4m−TWD 28.3m−TWD 138.2m−TWD 22.6m−TWD 99.9m−TWD 21.0m−TWD 22.1mTWD 1.5m
Diluted earnings per share0.07-0.09-0.42-0.07-0.30-0.06-0.070.00
Cash from operations−TWD 91.0m−TWD 56.0mTWD 101.0m−TWD 9.0m−TWD 68.0m−TWD 72.0mTWD 174.0mTWD 4.0m
Capital spending−TWD 32.0m−TWD 103.0m−TWD 3.0m−TWD 23.0m−TWD 14.0m−TWD 10.0m−TWD 5.0m−TWD 10.0m
Free cash flow−TWD 123.0m−TWD 159.0mTWD 98.0m−TWD 32.0m−TWD 82.0m−TWD 82.0mTWD 169.0m−TWD 6.0m
Total assetsTWD 4.76bnTWD 4.78bnTWD 3.93bnTWD 4.07bnTWD 4.14bnTWD 4.27bnTWD 4.36bnTWD 4.32bn
DebtTWD 704.7mTWD 708.1m——————
Shareholders' equityTWD 3.56bnTWD 3.52bnTWD 3.48bnTWD 3.61bnTWD 3.67bnTWD 3.77bnTWD 3.85bnTWD 3.86bn

Financial ratios

Data as of 2 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Operating margin-43.3%-24.1%-311.5%-398.7%43.2%-5729.9%——
Net margin-45.9%-13.3%-297.7%-411.3%43.0%-6002.4%——
Return on equity-8.1%-2.1%-30.2%-29.9%30.2%-22.0%——
Return on assets-7.2%-1.8%-19.0%-20.4%26.6%-19.8%——
Free cash flow yield—0.4%-2.2%-4.8%3.7%-2.9%-2.4%—
Revenue growth1.2%55.4%6.7%-88.9%28413.0%927.4%——
Earnings growth250.1%-93.1%-22.8%-206.5%-304.2%8.5%——
Current ratio12.77x11.94x2.21x15.38x8.47x12.48x——
Debt to equity——0.45x0.34x0.00x0.00x0.37x0.32x
Equity ratio88.4%88.2%63.1%68.4%88.2%90.0%——
Interest coverage-30.19x-7.71x-32.31x-54.12x235.30x-40.16x——
R&D as a share of sales55.2%36.6%306.0%312.3%36.4%5905.6%——
Buybacks as a share of market value—-0.1%-0.2%-4.1%-13.8%-16.4%1.1%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue18.9%121.5%—
Operating income-43.3%-16.6%3.8%
Net income-42.8%-16.4%4.5%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-33.8%-156.1%-44.1%—
Net margin-29.7%-153.2%-43.8%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-44.0-147.3-19.9-15.244.9-27.7-7.0-11.5-10.6-16.2
Price to sales20.219.659.162.419.3—————

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 1482.8058-for-1000 split · 3 Aug 2022

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.